Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

9.24
BATS BZX Real-Time Price
As of 12:14pm ET
 +0.225 / +2.49%
Today’s Change
8.31
Today|||52-Week Range
38.50
-36.33%
Year-to-Date

Today’s Trading

Previous close9.02
Today’s open9.21
Day’s range9.02 - 9.56
Volume762,044
Average volume (3 months)17,948,859
Market cap$3.1B
Dividend yield--
Data as of 12:14pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-29.17%
Earnings growth (next 5 years)+3.95%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...+0.84+1.48%
GWPHGW Pharmaceuticals P...+1.51+1.29%
CBPOChina Biologic Produ...+0.31+0.26%
ICPTIntercept Pharmaceut...-0.67-0.58%
Data as of 12:14pm ET, 04/26/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.92
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts


Search for Jobs